50 results
6-K
EX-99.1
INCR
Intercure Ltd
1 May 24
Current report (foreign)
7:10am
highlights the commitment of our team and the effectiveness of the Company’s operational strategy. As the global landscape for pharmaceutical cannabis … success of its global expansion plans, its expansion strategy to major markets worldwide, statements relating to the security events in Israel, as well
6-K
EX-99.1
INCR
Intercure Ltd
1 Apr 24
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million
8:40am
new GMP SKUs during 2023.
Expanding the Company’s partnership strategy, through an exclusive partnership agreement with premier cannabis brand TYSON … strategy to major markets worldwide, statements relating to the security events in Israel, as well as statements, other than historical facts
6-K
EX-99.1
INCR
Intercure Ltd
13 Feb 24
InterCure Provides an Update Regarding Nir Oz Facility
4:56pm
,” “anticipates,” “should,” “intends,” “plans,” “will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and similar expressions and are based … strategy, competitive strengths, goals and expansion and growth plans, expansion strategy to major markets worldwide, the impact of the COVID-19
6-K
EX-99.1
INCR
Intercure Ltd
31 Jan 24
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
9:00am
with the Company’s strategy of expanding its market-leading distribution network, towards the new medical cannabis reform announced by the Israeli Ministry … ,” “strategy” and similar expressions and are based on assumptions and assessments made in light of management’s experience and perception of historical
6-K
EX-99.1
5w1uvq5
31 Oct 23
Current report (foreign)
4:51pm
6-K
EX-99.1
a3p0nq
17 Oct 23
InterCure Provides an Update Regarding the Security Situation in Israel
5:20pm
6-K
EX-99.1
d71f9w4
31 Aug 23
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
5:28pm
6-K
EX-99.1
wsfsyg8lwe96tzjpeew
11 Jul 23
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
6:02am
6-K
EX-99.1
5whlfhx xt
12 Jun 23
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
8:00am
6-K
EX-99.2
e5eazfn58
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
EX-99.1
hfuzf0pc1oxos3
16 May 23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
6:06am
6-K
EX-99.1
n3jhvm8i pe9zk
26 Apr 23
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
8:00am
6-K
EX-99.1
faikv1pw ersfibmlr
20 Apr 23
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
8:51am
6-K
EX-99.2
0wfce4ouan0k3j0v49d
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.4
zatqivicsrxts4yn mvp
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.1
pxoa0fjo4ix8htn23
3 Apr 23
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
8:00am
6-K
EX-99.1
5d1er7 7o1nakaap
19 Dec 22
InterCure Announces Exclusive
8:43am
6-K
EX-99.1
2i3y3
23 Nov 22
Update regarding Better Transaction
4:45pm